Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History
Worth buying if: You want the human and corporate drama behind drug development.
Skip it if: You expect detailed lab protocols or exhaustive clinical data.
Exact edition: Hardcover · ISBN-13 9780060010300. The Amazon link uses this ISBN, so the product page should open to the edition shown here.
If this page helped you decide, purchasing through the Amazon button above supports UPB Books at no extra cost to you and helps us continue improving the site. Thanks for visiting today.
Check Amazon for the current price and availability of this exact edition.
As an Amazon Associate I earn from qualifying purchases. Some outbound links are paid links, at no additional cost to you.
Summary
Journalist Robert Slater and physician-executive Daniel Vasella trace the development, trials, and commercial race around a revolutionary oral cancer pill, blending human stories with industry strategy and scientific stakes.
Why this book now
Offers historical perspective on targeted oral therapies as oncology shifted toward precision drugs and biotech commercialization in the early 2000s.
30-second preview
Two quick cards, fifteen seconds each.
Card 1 of 2
Best for readers who...
Good fit if you want...
- You want the human and corporate drama behind drug development.
- You appreciate accessible explanations of medical science without heavy jargon.
- You expect detailed lab protocols or exhaustive clinical data.
- You prefer purely academic or technical oncology texts.
- You only want something with very current references and examples.
Decided it fits?
Exact edition: Hardcover · ISBN-13 9780060010300
Worth buying if: You want the human and corporate drama behind drug development.
Skip it if: You expect detailed lab protocols or exhaustive clinical data.
Check Amazon for the current price and availability of this exact edition.
Reader guide
Cues to help you decide faster.
Reading commitment
Balanced Moderate time
At roughly 288 pages, this narrative nonfiction moves steadily—plan on several evenings to absorb the stories, timelines, and explanations without needing a scientific background.
What stands out here
This HarperCollins 2003 trade edition frames the rise of oral targeted therapies through reporting and interviews, emphasizing people and business rather than dense science.
Best way to approach it
Read straight through for the narrative arc of discovery and development, pausing at technical sections to reflect on implications rather than expecting exhaustive clinical minutiae.
Was this page helpful?
Quick thumbs only. No login.
Loading feedback…
Hardcover: ISBN-13 9780060010300
Check Amazon for the current price and availability of this exact edition.